← All trials
NCT02354144
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 29, 2016
- Primary completion
- Mar 9, 2020
- Completion date
- Mar 9, 2020
- First posted
- Feb 3, 2015
- Last posted
- Jun 15, 2021
- Enrollment
- 258
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- McGill UniversityLead sponsor
- McGill UniversityOverall official - principal investigator
- McGill UniversityReponsible party - principal investigator
- University of MontrealCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.